BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25563814)

  • 1. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk.
    Barresi V; Branca G; Caffo M; Tuccari G
    J Neurooncol; 2015 Mar; 122(1):87-95. PubMed ID: 25563814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
    Barresi V; Alafaci C; Salpietro F; Tuccari G
    Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
    Barresi V; Cerasoli S; Vitarelli E; Tuccari G
    Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study.
    Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S
    J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG; Shishkina LV; Golanov AV
    Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?
    Barresi V; Vitarelli E; Tuccari G; Barresi G
    J Neurooncol; 2011 Apr; 102(2):189-96. PubMed ID: 20652360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of UbcH10 expression and its association with recurrence of meningiomas.
    Jiang L; Wang T; Bao Y; Qian J; Wu XJ; Hu GH; Lu YC
    J Surg Oncol; 2012 Sep; 106(3):327-31. PubMed ID: 22095464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
    Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
    Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
    Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
    Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
    Panagopoulos AT; Lancellotti CL; Veiga JC; de Aguiar PH; Colquhoun A
    J Neurooncol; 2008 Aug; 89(1):73-87. PubMed ID: 18418552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density.
    Barresi V; Vitarelli E; Cerasoli S
    Virchows Arch; 2009 May; 454(5):563-71. PubMed ID: 19296128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
    Barresi V; Tuccari G
    Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of meningiomas.
    Yamasaki F; Yoshioka H; Hama S; Sugiyama K; Arita K; Kurisu K
    Cancer; 2000 Sep; 89(5):1102-10. PubMed ID: 10964341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.